An oncolytic virus expressing a full-length antibody enhances antitumor innate immune response to glioblastoma
Oncolytic herpes simplex virus-1 lyses cancer cells while increases their immunogenicity. Blocking the CD47 “don’t eat me” signal on cancer cells promotes their phagocytosis by macrophages. Authors here show that oncolytic viruses expressing anti-CD47 antibodies improve glioblastoma survival in mous...
Guardado en:
Autores principales: | Bo Xu, Lei Tian, Jing Chen, Jing Wang, Rui Ma, Wenjuan Dong, Aimin Li, Jianying Zhang, E. Antonio Chiocca, Balveen Kaur, Mingye Feng, Michael A. Caligiuri, Jianhua Yu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a3ded407a8e84ba2981a8d05e9d3ad5a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
PTEN expression by an oncolytic herpesvirus directs T-cell mediated tumor clearance
por: Luke Russell, et al.
Publicado: (2018) -
The current status of oncolytic viral therapy for head and neck cancer
por: Matthew O. Old, et al.
Publicado: (2016) -
Multi-Omics Analysis of Glioblastoma Cells’ Sensitivity to Oncolytic Viruses
por: Anastasiya V. Lipatova, et al.
Publicado: (2021) -
Choindroitinase ABC I-mediated enhancement of oncolytic virus spread and anti tumor efficacy: a mathematical model.
por: Yangjin Kim, et al.
Publicado: (2014) -
Elucidating mechanisms of antitumor immunity mediated by live oncolytic vaccinia and heat-inactivated vaccinia
por: Yi Wang, et al.
Publicado: (2021)